PL2640365T3 - Kompozycja farmaceutyczna zawierająca sól prekursorową cyklu krebsa, zwłaszcza sól cytrynianową, i jej zastosowanie jako leku - Google Patents

Kompozycja farmaceutyczna zawierająca sól prekursorową cyklu krebsa, zwłaszcza sól cytrynianową, i jej zastosowanie jako leku

Info

Publication number
PL2640365T3
PL2640365T3 PL11796756T PL11796756T PL2640365T3 PL 2640365 T3 PL2640365 T3 PL 2640365T3 PL 11796756 T PL11796756 T PL 11796756T PL 11796756 T PL11796756 T PL 11796756T PL 2640365 T3 PL2640365 T3 PL 2640365T3
Authority
PL
Poland
Prior art keywords
salt
medicament
pharmaceutical composition
krebs cycle
particular citrate
Prior art date
Application number
PL11796756T
Other languages
English (en)
Inventor
Caroline Roussel-Maupetit
Luc-André Granier
Catherine Guittet
Original Assignee
Advicenne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44168750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2640365(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advicenne filed Critical Advicenne
Publication of PL2640365T3 publication Critical patent/PL2640365T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11796756T 2010-11-18 2011-11-18 Kompozycja farmaceutyczna zawierająca sól prekursorową cyklu krebsa, zwłaszcza sól cytrynianową, i jej zastosowanie jako leku PL2640365T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1059468A FR2967576B1 (fr) 2010-11-18 2010-11-18 Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament

Publications (1)

Publication Number Publication Date
PL2640365T3 true PL2640365T3 (pl) 2017-09-29

Family

ID=44168750

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11796756T PL2640365T3 (pl) 2010-11-18 2011-11-18 Kompozycja farmaceutyczna zawierająca sól prekursorową cyklu krebsa, zwłaszcza sól cytrynianową, i jej zastosowanie jako leku

Country Status (9)

Country Link
US (1) US9782352B2 (pl)
EP (1) EP2640365B1 (pl)
JP (2) JP6054871B2 (pl)
DK (1) DK2640365T3 (pl)
ES (1) ES2631577T3 (pl)
FR (1) FR2967576B1 (pl)
HU (1) HUE035229T2 (pl)
PL (1) PL2640365T3 (pl)
WO (1) WO2012066254A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
CA2918253C (en) 2013-08-06 2018-08-28 Ppg Industries Ohio, Inc. Deformable aircraft window
CN104739794A (zh) * 2013-12-26 2015-07-01 广州医药研究总院有限公司 一种新的枸橼酸钾缓释片及其制备方法
CN104800180A (zh) * 2015-04-02 2015-07-29 南京泽恒医药技术开发有限公司 枸橼酸钾双重缓释片的组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165181B (pl) 1971-11-08 1974-07-27
DE2931395A1 (de) 1979-08-02 1981-02-26 Henkel Kgaa Verfahren zur herstellung von gewuerzextrakten
JPH075457B2 (ja) 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
JPS6416A (en) * 1986-12-23 1989-01-05 Santen Pharmaceut Co Ltd Remedy for arthritis
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
US6887492B2 (en) 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
EP1896002A4 (en) * 2005-06-27 2009-11-25 Biovail Lab Int Srl BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
US20090028935A1 (en) * 2006-12-01 2009-01-29 Kristin Arnold Carvedilol forms, compositions, and methods of preparation thereof
US20080131504A1 (en) 2006-12-01 2008-06-05 Mission Pharmacal Co. Short Term Slow Release Drug Delivery System
EP1970066A1 (de) * 2007-03-12 2008-09-17 Medice Arzneimittel Pütter GmbH & Co. KG Pharmazeutische Zusammensetzung zur Behandlung einer Übersäuerung des Blutes
US20100221335A1 (en) 2007-08-31 2010-09-02 Daiichi Sankyo Company, Limited Sustained-release preparation and method for producing the same

Also Published As

Publication number Publication date
US20130224297A1 (en) 2013-08-29
JP2017061553A (ja) 2017-03-30
JP2014501722A (ja) 2014-01-23
WO2012066254A1 (fr) 2012-05-24
FR2967576A1 (fr) 2012-05-25
EP2640365A1 (fr) 2013-09-25
EP2640365B1 (fr) 2017-05-10
HUE035229T2 (en) 2018-05-02
JP6386011B2 (ja) 2018-09-05
ES2631577T3 (es) 2017-09-01
US9782352B2 (en) 2017-10-10
FR2967576B1 (fr) 2013-07-12
JP6054871B2 (ja) 2016-12-27
DK2640365T3 (en) 2017-07-24

Similar Documents

Publication Publication Date Title
EP2881395A4 (en) PIPERAZINOTRIZOLE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN THE PREPARATION OF MEDICAMENT
IL223795A (en) History of Tetrahydro-Pyrido-Pyrimidine
IL209348A0 (en) Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
EP2702054A4 (en) NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM, AND USE THEREOF
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
IL231170A (en) Nitrate mustard derivative compound, pharmaceutical preparation, use of drug preparation and compound for use as a drug
IL229204A (en) Hydroxystilbins that carry paranilations, medicinal preparations and their uses
IL223872A (en) Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them
IL211534A (en) Sulfur-related compounds, pharmaceutical preparations containing them and their uses for the preparation of a drug to inhibit at least one isomerase - trans cycle visual in patients
IL216105A0 (en) Non-cating salt composition, preparation process and use thereof
EP2786982A4 (en) AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2781512A4 (en) OXADIAZOLE COMPOUND AND PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2606898A4 (en) COMPOSITION COMPRISING FLAVONE OF TROÈNE, RHOIFOLINE AND HYPERIN AND USE THEREOF IN THE PREPARATION OF A MEDICAMENT
ZA201104882B (en) Pharmaceutical compositions with superior product performance and patient compliance
PL2640365T3 (pl) Kompozycja farmaceutyczna zawierająca sól prekursorową cyklu krebsa, zwłaszcza sól cytrynianową, i jej zastosowanie jako leku
HRP20160928T1 (hr) Farmaceutske kompozicije koje sadrže anakinra bez citrata
IL221737A (en) Its compound or salt, a pharmaceutical preparation containing it and its uses
IL217143A (en) Pharmaceuticals containing a compound of a manganese complex and a form other than the manganese complex of the compound and their uses for the preparation of drugs for the treatment of pathological conditions
IL213105A (en) Compounds, their preparation process, pharmaceutical preparations containing them and their use in the preparation of drugs
EP2933290A4 (en) COMPOSITION FOR COMPLEX FORMATION, COMPLEX FORMED THEREFROM, AND COMPOSITION FOR ORAL ADMINISTRATION COMPRISING SAID COMPLEX
ZA201303695B (en) Pharmaceutical composition comprising citrate and bicarbonate salts,and use thereof for treating cystinuria
SI2476420T1 (sl) Farmacevtski sestavek, ki ima antimikrobno in hitro-celilno aktivnost za zunanje dajanje, postopek za njegovo pripravo
EP2738176A4 (en) WATER-SOLUBLE CAMPTOTHECIN DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREFOR AND ITS USE
EP2926811A4 (en) ARTEMISCULAR PHARMACEUTICAL COMPOSITION, MANUFACTURE AND USE